DEFINITIVE 14A NOTICE AND PROXY

Company

FENNEC PHARMACEUTICALS INC.

Filed

April 1, 2009

Period of Report

May 19, 2009

Accession Number

0001193125-09-070409

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →